Mona Foth

10PUBLICATIONS
64CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Psychopharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 22, 2026
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multiselective Inhibitors in NRAS-Mutated Melanoma.

|Dec 25, 2025
Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma.

Mona Foth, Wontak Kim, Kayla T O'Toole

|Dec 05, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in Melanoma.

Catriona A Ford, Dana Koludrovic, Patricia P Centeno

|Nov 06, 2023
Genetic Silencing of AKT Induces Melanoma Cell Death via mTOR Suppression.

Gennie L Parkman, Tursun Turapov, David A Kircher

|Oct 30, 2021
The role of PI3'-lipid signalling in melanoma initiation, progression and maintenance.

Gennie L Parkman, Mona Foth, David A Kircher

|Jul 24, 2021
Autophagy Inhibition in BRAF-Driven Cancers.

Mona Foth, Martin McMahon

Pageof 2

Frequent Collaborators

8 joint publications

Martin McMahon

3 joint publications

Gennie Parkman

3 joint publications

Sheri L Holmen

2 joint publications

Kayla O'Toole